Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review
High myopia (≥ − 6.00 D) poses significant challenges to visual function and quality of life, with implantable collamer lens (ICL) V4c implantation emerging as a pivotal treatment. This mini review synthesizes evidence on visual-related quality of life (VRQoL) following ICL V4c implantation, focusin...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1630025/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850076833809170432 |
|---|---|
| author | Huailan Zhao Siquan Zhu |
| author_facet | Huailan Zhao Siquan Zhu |
| author_sort | Huailan Zhao |
| collection | DOAJ |
| description | High myopia (≥ − 6.00 D) poses significant challenges to visual function and quality of life, with implantable collamer lens (ICL) V4c implantation emerging as a pivotal treatment. This mini review synthesizes evidence on visual-related quality of life (VRQoL) following ICL V4c implantation, focusing on predictability, objective/subjective visual quality, and complications. ICL V4c demonstrates long-term safety and efficacy, with safety indices (postoperative best-corrected visual acuity/preoperative best-corrected visual acuity) of 1.01–1.10 and efficacy indices (postoperative uncorrected visual acuity/preoperative best-corrected visual acuity) exceeding 0.90 over 5 years. Objective metrics, including higher-order aberrations and intraocular scattering, remain stable or improve postoperatively, while subjective outcomes show high patient satisfaction despite common but mild issues like halos (90.1% incidence) and glare (66.7% incidence). Complications such as cataract (1.7–6.8% incidence), corneal endothelial cell loss (≤5.7% over 8 years), and ICL malposition are rare and often manageable. While axial length progression in super-high myopia requires monitoring, ICL V4c remains a robust option for enhancing VRQoL in high myopia patients. Future research should prioritize large-scale, long-term studies to validate outcomes and optimize surgical protocols. |
| format | Article |
| id | doaj-art-3e8e6f546ced479eba6cd70d3e8188af |
| institution | DOAJ |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-3e8e6f546ced479eba6cd70d3e8188af2025-08-20T02:45:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-07-011210.3389/fmed.2025.16300251630025Visual related quality of life after ICL V4c implantation in high myopia patients: a mini reviewHuailan ZhaoSiquan ZhuHigh myopia (≥ − 6.00 D) poses significant challenges to visual function and quality of life, with implantable collamer lens (ICL) V4c implantation emerging as a pivotal treatment. This mini review synthesizes evidence on visual-related quality of life (VRQoL) following ICL V4c implantation, focusing on predictability, objective/subjective visual quality, and complications. ICL V4c demonstrates long-term safety and efficacy, with safety indices (postoperative best-corrected visual acuity/preoperative best-corrected visual acuity) of 1.01–1.10 and efficacy indices (postoperative uncorrected visual acuity/preoperative best-corrected visual acuity) exceeding 0.90 over 5 years. Objective metrics, including higher-order aberrations and intraocular scattering, remain stable or improve postoperatively, while subjective outcomes show high patient satisfaction despite common but mild issues like halos (90.1% incidence) and glare (66.7% incidence). Complications such as cataract (1.7–6.8% incidence), corneal endothelial cell loss (≤5.7% over 8 years), and ICL malposition are rare and often manageable. While axial length progression in super-high myopia requires monitoring, ICL V4c remains a robust option for enhancing VRQoL in high myopia patients. Future research should prioritize large-scale, long-term studies to validate outcomes and optimize surgical protocols.https://www.frontiersin.org/articles/10.3389/fmed.2025.1630025/fullhigh myopiaICL V4cvisual-related quality of lifeobjective visual qualitysubjective visual qualitycomplications |
| spellingShingle | Huailan Zhao Siquan Zhu Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review Frontiers in Medicine high myopia ICL V4c visual-related quality of life objective visual quality subjective visual quality complications |
| title | Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review |
| title_full | Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review |
| title_fullStr | Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review |
| title_full_unstemmed | Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review |
| title_short | Visual related quality of life after ICL V4c implantation in high myopia patients: a mini review |
| title_sort | visual related quality of life after icl v4c implantation in high myopia patients a mini review |
| topic | high myopia ICL V4c visual-related quality of life objective visual quality subjective visual quality complications |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1630025/full |
| work_keys_str_mv | AT huailanzhao visualrelatedqualityoflifeaftericlv4cimplantationinhighmyopiapatientsaminireview AT siquanzhu visualrelatedqualityoflifeaftericlv4cimplantationinhighmyopiapatientsaminireview |